Understanding the biological activity of progesterone receptors (PRs), estrogen receptors (ERs), and human epidermal growth factor receptor 2 (also known as receptor tyrosine–protein kinase EGRB-2 or tyrosine kinase-type cell surface receptor HER2) for various subtypes of breast cancer has advanced. This evidence concerns the gene ERBB2 and breast carcinoma.